Success Metrics

Clinical Success Rate

100.0%

Based on 3 completed trials

Completion Rate

100%(3/3)

Active Trials

0(0%)

Results Posted

0%(0 trials)

Phase Distribution

Ph not_applicable

25%

Ph phase_4

50%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution3 total trials

Phase 4Post-market surveillance

2(66.7%)

N/ANon-phased studies

1(33.3%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

3 of 3 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Completed(3)

Other(1)

Detailed Status

Completed3

unknown1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

100.0%

Most Advanced

Phase 4

Trials by Phase

Phase 42 (66.7%)

N/A1 (33.3%)

Trials by Status

unknown125%

completed375%

Recent Activity

0 active trials

Showing 4 of 4

completed

Compliance With Once-Daily Divalproex Extended-Release Tablets (Depakote-ER) Versus Multiple-Daily Dose Valproic Acid Capsules (Depakene) in Epilepsy:

NCT00356018

unknownnot_applicable

Brief Interventions to Increase HPV Vaccine Acceptance in School-based Health Centers

NCT01087164

completedphase_4

Study to Improve Quality of Care and Patient Health in the Field of Cardiovascular Risk Factors in General Practice

NCT00348855

completedphase_4

To Assess Compliance With a Once-daily Regimen of Lamivudine, Efavirenz and Didanosine

NCT00207168

Clinical Trials (4)

Showing 4 of 4 trials

NCT00356018

Compliance With Once-Daily Divalproex Extended-Release Tablets (Depakote-ER) Versus Multiple-Daily Dose Valproic Acid Capsules (Depakene) in Epilepsy:

Completed

NCT01087164Not Applicable

Brief Interventions to Increase HPV Vaccine Acceptance in School-based Health Centers

Unknown

NCT00348855Phase 4

Study to Improve Quality of Care and Patient Health in the Field of Cardiovascular Risk Factors in General Practice

Completed

NCT00207168Phase 4

To Assess Compliance With a Once-daily Regimen of Lamivudine, Efavirenz and Didanosine

Completed

All 4 trials loaded

Drug Details

Intervention Type: BEHAVIORAL
Total Trials: 4